SS
AMRX icon

SBI Securities’s Amneal Pharmaceuticals AMRX Stock Holding History

SBI Securities’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.82K Buy
163
+125
+329% +$1.71K ﹤0.01% 2430
2026
Q1 		$472 Sell
38
-88
-70% -$1.18K ﹤0.01% 2913
2025
Q4 		$1.59K Buy
126
+86
+215% +$984 ﹤0.01% 2480
2025
Q3 		$400 Buy
40
+2
+5% +$18 ﹤0.01% 3062
2025
Q2 		$307 Hold
38
– – ﹤0.01% 3167
2025
Q1 		$318 Hold
38
– – ﹤0.01% 3046
2024
Q4 		$301 Buy
+38
New +$319 ﹤0.01% 3087

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

SBI Securities's AMRX Position: Q2 2026 in Review

SBI Securities increased its Amneal Pharmaceuticals (AMRX) stake by 329% in Q2 2026, buying an estimated $1.71K and bringing the position to 163 shares worth $2.82K. The position accounts for ﹤0.01% of the portfolio, ranked #2430.

SBI Securities first reported a position in AMRX in Q4 2024 and has held it in 7 quarters since. 306 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • SBI Securities held 163 shares of Amneal Pharmaceuticals worth $2.82K as of Q2 2026.
  • SBI Securities bought 125 Amneal Pharmaceuticals shares in Q2 2026, an estimated $1.71K.
  • Amneal Pharmaceuticals made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2430 holding.
  • SBI Securities first reported a position in Amneal Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 306 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.